Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 145
- +5 vs. Q1 2024
- Shares held
- 76.7M
- −8.58M (−10.1%) vs. Q1 2024
- Total value
- $314.3M
- −$1.03B (−76.6%) vs. Q1 2024
- New holders
- 26
- 56 more added
- Sold out
- 21
- 42 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 107,100 | $438.0K | 0.00% | −160,765−60.0% | Reduced |
| Alliancebernstein L.P. | 110,738 | $452.9K | 0.00% | +53,020+91.9% | Added |
| UBS Asset Management Americas Inc | 113,386 | $463.7K | 0.00% | +45,914+68.0% | Added |
| Manufacturers Life Insurance Company, The | 129,129 | $528.1K | 0.00% | −2,686−2.0% | Reduced |
| Nuveen Asset Management, LLC | 130,308 | $533.0K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 148,755 | $608.4K | 0.00% | +125,649+543.8% | Added |
| Rafferty Asset Management, LLC | 167,564 | $685.3K | 0.00% | −130,444−43.8% | Reduced |
| Jane Street Group, LLC | 172,989 | $707.5K | 0.00% | +48,702+39.2% | Added |
| XTX Topco Ltd | 178,465 | $729.9K | 0.06% | +167,854+1,581.9% | Added |
| Mayo Clinic | 187,143 | $765.4K | 25.27% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 240,341 | $983.0K | 0.00% | +226,050+1,581.8% | Added |
| Gsa Capital Partners LLP | 255,201 | $1.04M | 0.07% | +244,599+2,307.1% | Added |
| Bank of Montreal | 98,331 | $1.13M | 0.00% | +98,331 | New |
| Bank of New York Mellon Corp | 333,719 | $1.36M | 0.00% | +43,839+15.1% | Added |
| Millennium Management LLC | 392,608 | $1.61M | 0.00% | +146,286+59.4% | Added |
| Boxer Capital, LLC | 450,000 | $1.84M | 0.10% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 468,413 | $1.92M | 0.00% | +12,476+2.7% | Added |
| Federated Hermes, Inc. | 482,481 | $1.97M | 0.00% | −1,516,219−75.9% | Reduced |
| 5AM Venture Management, LLC | 490,000 | $2.00M | 0.45% | 00.0% | Unchanged |
| Northern Trust Corp | 495,266 | $2.03M | 0.00% | −28,436−5.4% | Reduced |
| JPMorgan Chase & Co | 495,810 | $2.03M | 0.00% | +437,189+745.8% | Added |
| Bank of America Corp | 508,233 | $2.08M | 0.00% | +32,277+6.8% | Added |
| Verition Fund Management LLC | 552,820 | $2.26M | 0.02% | −602,416−52.1% | Reduced |
| Goldman Sachs Group Inc | 619,253 | $2.53M | 0.00% | +287,253+86.5% | Added |
| Dimensional Fund Advisors LP | 626,663 | $2.56M | 0.00% | −96,993−13.4% | Reduced |
| Renaissance Technologies LLC | 661,682 | $2.71M | 0.00% | +399,745+152.6% | Added |
| Capital International Investors | 675,371 | $2.76M | 0.00% | −2,144,293−76.0% | Reduced |
| Two Sigma Advisers, LP | 796,900 | $3.26M | 0.01% | +695,900+689.0% | Added |
| Price T Rowe Associates Inc | 923,901 | $3.78M | 0.00% | −2,565,808−73.5% | Reduced |
| Tybourne Capital Management (HK) Ltd | 961,486 | $3.93M | 0.80% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 1,052,398 | $4.30M | 0.01% | +807,403+329.6% | Added |
| Primecap Management Co | 1,232,340 | $5.04M | 0.00% | +67,730+5.8% | Added |
| T. Rowe Price Investment Management, Inc. | 1,325,491 | $5.42M | 0.00% | −1,993,595−60.1% | Reduced |
| Geode Capital Management, LLC | 1,334,459 | $5.46M | 0.00% | +32,222+2.5% | Added |
| MPM Oncology Impact Management LP | 1,450,000 | $5.93M | 0.92% | −66,183−4.4% | Reduced |
| Woodline Partners LP | 1,517,077 | $6.20M | 0.06% | +80,051+5.6% | Added |
| Morgan Stanley | 1,950,722 | $7.98M | 0.00% | +913,313+88.0% | Added |
| State Street Corp | 3,052,392 | $12.5M | 0.00% | −733,260−19.4% | Reduced |
| Decheng Capital LLC | 3,070,442 | $12.6M | 3.85% | +970,859+46.2% | Added |
| Citadel Advisors LLC | 4,502,913 | $18.4M | 0.02% | +650,484+16.9% | Added |
| BlackRock Inc. | 4,818,546 | $19.7M | 0.00% | +172,788+3.7% | Added |
| Vanguard Group Inc | 5,654,757 | $23.1M | 0.00% | +1,256,132+28.6% | Added |
| Eventide Asset Management, LLC | 8,547,896 | $35.0M | 0.60% | −3,026,925−26.2% | Reduced |
| FMR LLC | 8,676,723 | $35.5M | 0.00% | −1,967,301−18.5% | Reduced |
| Matrix Capital Management Company, LP | 13,959,973 | $57.1M | 0.43% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −944,917−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −118,648−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −113,750−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −37,830−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −35,303−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −28,701−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −25,307−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −17,573−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −15,396−100.0% | Sold out |
| Heritage Wealth Management, Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −11,978−100.0% | Sold out |
| OneAscent Financial Services LLC | 0 | $0 | 0.00% | −11,427−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −9,043−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −3,392−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,388−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −1,357−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cutler Group LP | – | – | – | – | Not filed |